Sung Lee Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Sung Lee is EVP & Chief Financial Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 100,492 shares of VIR, which is worth approximately $750,675. The most recent transaction as insider was on Mar 27, 2024, when has been sold 6,008 shares (Common Stock) at a price of $9.89 per share, resulting in proceeds of $59,419. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
51.12% 12M change
Total Value Held $750,675

Sung Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 27 2024
SELL
Open market or private sale
$59,419 $9.89 p/Share
6,008 Reduced 5.64%
100,492 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 27.3%
106,500 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
66,500 Added 50.0%
66,500 Common Stock

Also insider at

SGMO
SANGAMO THERAPEUTICS, INC Healthcare
EVP, Chief Financial Officer
CYTK
CYTOKINETICS INC Healthcare
EVP, Chief Financial Officer
SL

Sung Lee

EVP & Chief Financial Officer
Brisbane, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR